Correlation Between 23Andme Holding and GT Biopharma
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and GT Biopharma, you can compare the effects of market volatilities on 23Andme Holding and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and GT Biopharma.
Diversification Opportunities for 23Andme Holding and GT Biopharma
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between 23Andme and GTBP is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and GT Biopharma go up and down completely randomly.
Pair Corralation between 23Andme Holding and GT Biopharma
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the GT Biopharma. In addition to that, 23Andme Holding is 1.89 times more volatile than GT Biopharma. It trades about -0.1 of its total potential returns per unit of risk. GT Biopharma is currently generating about -0.07 per unit of volatility. If you would invest 305.00 in GT Biopharma on September 4, 2024 and sell it today you would lose (26.00) from holding GT Biopharma or give up 8.52% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
23Andme Holding Co vs. GT Biopharma
Performance |
| Timeline |
| 23Andme Holding |
| GT Biopharma |
23Andme Holding and GT Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and GT Biopharma
The main advantage of trading using opposite 23Andme Holding and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| GT Biopharma vs. Candel Therapeutics | GT Biopharma vs. Cingulate Warrants | GT Biopharma vs. Unicycive Therapeutics | GT Biopharma vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world |